Globus Medical, Inc. (GMED) Stock

Globus Medical, Inc. (GMED) is a Healthcare stock trading at $79.22 (as of 2026-06-18), with a market capitalization of $11.11B and a trailing P/E of 19.1. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal conditions, with offerings that include spine systems (such as fusion and motion preservation products), interventional pain management, and orthopedic trauma and joint products. It also distributes human cell, tissue, and cellular and tissue-based products.

Valuation — source: SEC EDGAR (first-party)
Price$79.22
Market Cap$11.11B
P/E Ratio19.1
EV / EBITDA13.0
Price / Book2.35
Price / Sales3.58
DCF Value (model)$113.73
DCF Upside vs Price43.6%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$2.94B
Net Margin18.3%
Return on Equity12.4%
Current Ratio4.56
Revenue Growth (YoY)27.0%
EPS Growth (YoY)67.3%
FCF Growth (YoY)15.3%
Financial Health — source: SEC EDGAR
Altman Z-Score10.40 (safe)
Valuation vs Sector & Industry
Stock P/E19.1
Sector P/E (Healthcare)21.0
Industry P/E (Medical Equipment)31.7
vs Sector-8.7%
vs Industry-39.7%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($921.07M)
Institutional Holders Tracked10
Congressional Trades (recent)9
Company
SectorHealthcare
IndustryMedical Equipment
CEOKeith W. Pfeil
Employees5,300
CountryUS
IPO Date2012-08-03

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Solventum Corporation (SOLV)
  • The Cooper Companies, Inc. (COO)
  • Penumbra, Inc. (PEN)
  • Align Technology, Inc. (ALGN)
  • Revvity, Inc. (RVTY)
  • Baxter International Inc. (BAX)
  • Repligen Corporation (RGEN)
  • Bio-Rad Laboratories, Inc. (BIO)
GMED earnings history · GMED institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.